Trial Profile
A retrospective trial to assess adjuvant gimeracil/oteracil/tegafur compliance in patients with gastric cancer and varying levels of renal function
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Aug 2015
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 09 Aug 2015 New trial record